Trager W, Lanners H N, Stanley H A, Langreth S G
Parasite Immunol. 1983 May;5(3):225-36. doi: 10.1111/j.1365-3024.1983.tb00739.x.
Summary Aotus trivirgatus monkeys of karyotype 2 were treated as follows. Three received two injections of purified merozoites of a knobless (K-) clone of Plasmodium falciparum with muramyl dipeptide as adjuvant; three received similar injections but with merozoites of a wild-type knobby (K+) strain; three controls received MDP with human erythrocytes in the amounts estimated to be present as contaminants in the merozoite preparations. A month after the second injection all nine monkeys were inoculated with parasites of the wild-type knobby strain from another infected Aotus. The monkeys that had received the K- material developed only extremely low infections markedly different from the infections in the controls. Of those that received K+ material, one died early with low parasitaemia, one was protected and one had the same level of infection as the controls. In the combined group of immunized animals, four out of six were protected.
摘要 对核型为2的三带犰狳猴进行如下处理。三只猴子接受两次注射,注射对象为恶性疟原虫无结(K-)克隆的纯化裂殖子,并以胞壁酰二肽作为佐剂;三只猴子接受类似注射,但注射对象为野生型有结(K+)菌株的裂殖子;三只对照猴子接受的胞壁酰二肽与人红细胞的量估计与裂殖子制剂中的污染物量相同。第二次注射一个月后,所有九只猴子均接种来自另一只感染三带犰狳的野生型有结菌株的寄生虫。接受K-物质的猴子仅出现极低的感染情况,与对照组的感染情况明显不同。接受K+物质的猴子中,一只因低寄生虫血症早死,一只受到保护,一只的感染水平与对照组相同。在免疫动物的合并组中,六只中有四只受到保护。